American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$544M |
| 2 |
Apple
AAPL
|
+$224M |
| 3 |
Exxon Mobil
XOM
|
+$219M |
| 4 |
Meta Platforms (Facebook)
META
|
+$189M |
| 5 |
CRH
CRH
|
+$177M |
Top Sells
| 1 |
UnitedHealth
UNH
|
+$402M |
| 2 |
Colgate-Palmolive
CL
|
+$255M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$235M |
| 4 |
Starbucks
SBUX
|
+$175M |
| 5 |
Equinix
EQIX
|
+$168M |
Sector Composition
| 1 | Technology | 27.37% |
| 2 | Financials | 12.82% |
| 3 | Healthcare | 11.58% |
| 4 | Consumer Discretionary | 11.43% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
INZY
2626
DELISTED
Inozyme Pharma
INZY
| $255K | ﹤0.01% |
57,100
+5,673
| +11% | +$25.3K |
|
2627
Papa John's
PZZA
$1.65B
| $253K | ﹤0.01% |
5,386
+827
| +18% | +$38.9K |
|
2628
AerSale
ASLE
$401M
| $252K | ﹤0.01% |
36,480
+4,134
| +13% | +$28.6K |
|
2629
Norwood Financial Corp
NWFL
$245M
| $251K | ﹤0.01% |
9,871
-376
| -4% | -$9.54K |
|
2630
FRP Holdings
FRPH
$483M
| $250K | ﹤0.01% |
+8,779
| New | +$250K |
|
|
SRG
2631
Seritage Growth Properties
SRG
$237M
| $250K | ﹤0.01% |
53,468
+5,519
| +12% | +$25.8K |
|
2632
Valhi
VHI
$458M
| $249K | ﹤0.01% |
13,983
-93
| -0.7% | -$1.66K |
|
|
CHCT
2633
Community Healthcare Trust
CHCT
$445M
| $249K | ﹤0.01% |
10,625
+552
| +5% | +$12.9K |
|
2634
HilleVax
HLVX
$105M
| $248K | ﹤0.01% |
17,158
+1
| +0% | +$14 |
|
2635
ESSA Pharma
EPIX
$9.6M
| $246K | ﹤0.01% |
46,748
+572
| +1% | +$3.01K |
|
2636
Sight Sciences
SGHT
$181M
| $240K | ﹤0.01% |
35,948
+8,527
| +31% | +$56.9K |
|
2637
Donegal Group Class A
DGICA
$711M
| $237K | ﹤0.01% |
18,416
-88
| -0.5% | -$1.13K |
|
2638
Janux Therapeutics
JANX
$1.45B
| $236K | ﹤0.01% |
5,627
-21,428
| -79% | -$898K |
|
|
SIX
2639
DELISTED
Six Flags Entertainment Corp.
SIX
| $234K | ﹤0.01% |
7,058
-20,532
| -74% | -$680K |
|
2640
Xenon Pharmaceuticals
XENE
$2.79B
| $233K | ﹤0.01% |
5,979
-3,676
| -38% | -$143K |
|
2641
XPeng
XPEV
$19.9B
| $233K | ﹤0.01% |
31,797
| – | – |
|
2642
Holley
HLLY
$370M
| $230K | ﹤0.01% |
64,383
+12,186
| +23% | +$43.6K |
|
2643
Asure Software
ASUR
$215M
| $228K | ﹤0.01% |
27,145
+4,756
| +21% | +$40K |
|
2644
Dyne Therapeutics
DYN
$1.87B
| $228K | ﹤0.01% |
+6,451
| New | +$228K |
|
|
NVRO
2645
DELISTED
NEVRO CORP.
NVRO
| $227K | ﹤0.01% |
27,011
+1,907
| +8% | +$16.1K |
|
2646
Alector
ALEC
$278M
| $227K | ﹤0.01% |
50,083
-21,346
| -30% | -$96.9K |
|
2647
IonQ
IONQ
$16.6B
| $222K | ﹤0.01% |
31,604
| – | – |
|
2648
SkyWater Technology
SKYT
$509M
| $219K | ﹤0.01% |
28,651
-4,187
| -13% | -$32K |
|
2649
Richardson Electronics
RELL
$141M
| $218K | ﹤0.01% |
18,372
+2,359
| +15% | +$28K |
|
2650
BrightSpring Health Services
BTSG
$4.69B
| $216K | ﹤0.01% |
+19,029
| New | +$216K |
|